Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BiodaTech is a Chilean biotechnology company founded in 2021 that specializes in the production of standardized natural extracts of botanical origin. The company's flagship product, Anthocyanol, is a patented, high-bioavailability extract of the Maqui Berry (Aristotelia chilensis), which is exceptionally rich in anthocyanins and polyphenols. BiodaTech focuses on the anti-aging, anti-inflammatory, and antioxidant properties of its extracts, targeting cellular health, DNA protection, and telomere maintenance. The company offers various versions of Anthocyanol for use in functional foods, dietary supplements, and cosmetics, and is also pioneering the use of its proprietary "Maqui ink" for 2D and 3D printing of personalized pharmaceutical dosages.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Anthocyanol.